Published in Medical Letter on the CDC and FDA, April 17th, 2005
The U.S. is in the process of developing a strong microbial forensic program to attribute and prosecute such attacks, and perhaps deter them.
The opportunities and challenges facing the new field of microbial forensics were presented at the 229th National Meeting of the American Chemical Society in San Diego.
"It is imperative to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.